Drug name - Sernivo
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9775851 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
| US9364485 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
| US9655907 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
| US10179137 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
| US9433630 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
| US9877974 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
| US9439911 | PRIMUS PHARMS | Topical formulations comprising a steroid |
Aug, 2030
(7 years from now) | |
Drugs and Companies using BETAMETHASONE DIPROPIONATE ingredient
Treatment: Treatment of plaque psoriasis
Dosage: SPRAY;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 0.05% BASE/SPRAY | SPRAY;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.